These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 10874131
1. Kinetics of human acetylcholinesterase inhibition by the novel experimental Alzheimer therapeutic agent, tolserine. Kamal MA, Greig NH, Alhomida AS, Al-Jafari AA. Biochem Pharmacol; 2000 Aug 15; 60(4):561-70. PubMed ID: 10874131 [Abstract] [Full Text] [Related]
2. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine. al-Jafari AA, Kamal MA, Greig NH, Alhomida AS, Perry ER. Biochem Biophys Res Commun; 1998 Jul 09; 248(1):180-5. PubMed ID: 9675107 [Abstract] [Full Text] [Related]
3. Kinetic analysis of the toxicological effect of tacrine (Cognex) on human retinal acetylcholinesterase activity. Alhomida AS, Al-Rajhi AA, Kamal MA, Al-Jafari AA. Toxicology; 2000 May 19; 147(1):33-9. PubMed ID: 10837930 [Abstract] [Full Text] [Related]
4. Kinetics for camel (Camelus dromedarius) retina acetylcholinesterase inhibition by methotrexate in vitro. al-Jafari A, al-Khwyter F, Kamal MA, Alhomida AS. Jpn J Pharmacol; 1996 Sep 19; 72(1):49-55. PubMed ID: 8902599 [Abstract] [Full Text] [Related]
5. Evaluation of the nature of camel retinal acetylcholinesterase: inhibition by hexamethonium. Alhomida AS, Kamal MA, al-Jafari AA. J Enzyme Inhib; 1997 Dec 19; 12(4):303-11. PubMed ID: 9502051 [Abstract] [Full Text] [Related]
6. Effect of malathion on kinetic parameters of acetylcholinesterase (EC 3.1.1.7) in vitro. Kamal MA. Biochem Mol Biol Int; 1997 Sep 19; 43(1):89-97. PubMed ID: 9315286 [Abstract] [Full Text] [Related]
8. Characterization of human erythrocyte membrane-bound acetylcholinesterase inhibition by cisplatin at reversible phase. Kamal MA. Anticancer Res; 1996 Sep 19; 16(6B):3725-30. PubMed ID: 9042248 [Abstract] [Full Text] [Related]
9. In vitro inhibition of human erythrocyte acetylcholinesterase (EC3.1.1.7) by an antineoplastic drug methotrexate. Kamal MA, Nasim FH, al-Jafari AA. Mol Cell Biochem; 1996 Jun 07; 159(1):47-53. PubMed ID: 8813709 [Abstract] [Full Text] [Related]
10. Effect of sevin on kinetic parameters of camel retina acetylcholinesterase. Kamal MA. Biochem Mol Biol Int; 1997 Jun 07; 42(2):235-46. PubMed ID: 9238521 [Abstract] [Full Text] [Related]
11. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease. Yu Q, Holloway HW, Utsuki T, Brossi A, Greig NH. J Med Chem; 1999 May 20; 42(10):1855-61. PubMed ID: 10346939 [Abstract] [Full Text] [Related]
12. Investigation of the effect of lannate on kinetic parameters of acetylcholinesterase: slightly concave mixed-type of inhibition system. Kamal MA. Biochem Mol Biol Int; 1997 Dec 20; 43(6):1183-93. PubMed ID: 9442915 [Abstract] [Full Text] [Related]
13. Kinetics of the inhibition of acetylcholinesterase from desert cobra (Walterinnesia aegyptia) venom by local anesthetics: procaine and tetracaine. al-Jafari AA, Kamal MA, Duhaiman AS, Alhomida AS. J Enzyme Inhib; 1996 Oct 20; 11(2):123-34. PubMed ID: 9204401 [Abstract] [Full Text] [Related]
17. Computational and Kinetic Studies of Acetylcholine Esterase Inhibition by Phenserine. Tabrez S, Damanhouri GA. Curr Pharm Des; 2019 Oct 20; 25(18):2108-2112. PubMed ID: 31258059 [Abstract] [Full Text] [Related]
18. Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase. Perola E, Cellai L, Lamba D, Filocamo L, Brufani M. Biochim Biophys Acta; 1997 Nov 14; 1343(1):41-50. PubMed ID: 9428657 [Abstract] [Full Text] [Related]